Vir Biotechnology, Inc. VIR
11.49 USD +0.27 (+2.41%)
Nov 4, 2026, 12:17 PM EST
11.17 Day range 11.81
4.82 52-week range 12.19
- YTD
- +90.55%
- 1 year
- +118.86%
Held by funds
143 US ETFs and mutual funds hold VIR · largest positions
Ownership
Held by insiders 6.58%
Held by institutions 85.16%
Float held by institutions 91.15%
Institutions 351
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 12.22% | 20,678,283 | 232.01M | Jun 29, 2026 |
| Arch Venture Management, Llc | 7.50% | 12,694,163 | 142.43M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 6.79% | 11,495,215 | 128.98M | Jun 29, 2026 |
| SB Investment Advisers (UK) LTD | 6.47% | 10,948,093 | 122.84M | Jun 29, 2026 |
| State Street Corporation | 5.89% | 9,964,151 | 111.80M | Jun 29, 2026 |
| GSK plc | 5.05% | 8,550,954 | 95.94M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.86% | 4,846,948 | 54.38M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.09% | 3,533,092 | 39.64M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.05% | 3,476,669 | 39.01M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.50% | 2,546,144 | 28.57M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.18% | 1,996,625 | 22.40M | Jun 29, 2026 |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | 1.04% | 1,762,412 | 19.77M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DE BACKER MARIANNE | Chief Executive Officer | Sale | Apr 5, 2026 | 1,001,260 |
| DE VERNEUIL VANINA ALEXANDRA HUARD | General Counsel | Sale | Feb 24, 2026 | 112,982 |
| EISNER MARK E | Officer | Sale | Feb 24, 2026 | 154,024 |
| HANLY ANN M | Chief Technology Officer | Sale | Feb 23, 2025 | 117,901 |
| MORE ROBERT J | Director | Stock Award(Grant) | May 26, 2026 | 558,573 |
| O'BYRNE JASON | Chief Financial Officer | Sale | Feb 23, 2026 | 162,615 |